These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5157620)

  • 21. [Combined rifampicin-ethambutol therapy of resistent pulmonary tuberculosis. Effectiveness of various rifampicin doses in combination with ethambutol].
    Hetrick C; Ras R; Turri M
    Dtsch Med Wochenschr; 1970 Sep; 95(36):1830-3. PubMed ID: 5453003
    [No Abstract]   [Full Text] [Related]  

  • 22. A resected case of Mycobacterium szulgai pulmonary disease.
    Tsuyuguchi K; Amitani R; Matsumoto H; Tanaka E; Suzuki K; Yanagihara K; Mizuno H; Hitomi S; Kuze F
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):258-60. PubMed ID: 9526201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of Mycobacterium intracellular infection with antibacterial drugs (author's transl)].
    Tamura M; Yamada M; Ikegaki H; Takasawa N
    Kekkaku; 1979 Feb; 54(2):75-84. PubMed ID: 439569
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative studies of various antituberculosis drug regimens by means of serum antimycobacterial activity tests in man.
    Hokama S
    Jpn J Tuberc; 1967 Jul; 14(1):55-65. PubMed ID: 5300098
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results of 6-month and 9-month treatments with rifampin, isoniazid and ethambutol in cases of newly detected tuberculosis].
    Szymanski A; Gaik A
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1981; 30(3):181-3. PubMed ID: 6273991
    [No Abstract]   [Full Text] [Related]  

  • 26. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
    Belianin II; Shmelev EI
    Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Results of intermittent treatment of tuberculosis and Mycobacteria shedding in children].
    Rudnik J; Majewska-Zalewska H
    Pediatr Pol; 1983 Dec; 58(12):941-55. PubMed ID: 6422437
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bacteriologic results of treatment with rifampicin and ethambutol administered continuously or intermittently in experimental tuberculosis in white mice].
    Sosnowski W; Tomaszkiewicz L
    Gruzlica; 1973 Mar; 41(3):213-24. PubMed ID: 4696134
    [No Abstract]   [Full Text] [Related]  

  • 29. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Four drug combination including Ethambutol and early switching to entirely new regimen in initial treatment of pulmonary tuberculosis].
    Kekkaku; 1970 Jul; 45(7):219-26. PubMed ID: 5449509
    [No Abstract]   [Full Text] [Related]  

  • 31. Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.
    Pérez-Guzmán C; Vargas MH; Martínez-Rossier LA; Torres-Cruz A; Villarreal-Velarde H
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1102-9. PubMed ID: 12546119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Short-course chemotherapy for pulmonary tuberculosis. 1. Clinical effect of RFP, INH and EB regimen for 9 months in the original treatment for pulmonary tuberculosis (author's transl)].
    Oda T
    Kekkaku; 1980 Jul; 55(7):331-9. PubMed ID: 7206413
    [No Abstract]   [Full Text] [Related]  

  • 34. [Combined treatment with capreomycin, ethambutol and rifampizin in chronic open pulmonary tuberculosis].
    Virchow C; Flemming J
    Beitr Klin Erforsch Tuberk Lungenkr; 1969; 140(1):40-6. PubMed ID: 5824389
    [No Abstract]   [Full Text] [Related]  

  • 35. [Miss-management in treatment failure of pulmonary tuberculosis].
    Ito K; Yoshiyama T; Wada M; Ogata H
    Kekkaku; 2004 Oct; 79(10):561-7. PubMed ID: 15631107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rifampicin and ethambutol in the treatment of chronic destructive tuberculosis].
    Shmelev NA; Korotaev GA; Kaminskaia AA
    Probl Tuberk; 1971; 49(7):21-4. PubMed ID: 5162993
    [No Abstract]   [Full Text] [Related]  

  • 37. [Drug-resistant pulmonary tuberculosis at the penitentiaries].
    Kononets AS
    Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tuberculosis treated with rifampicin, ethambutol and isoniazid: Danish tuberculosis trial 1972-1974.
    Engbaek HC; Heckscher T; Højgaard C; Larsen SO; Rasmussen KN; Vergmann B
    Eur J Respir Dis; 1982 Mar; 63(2):84-93. PubMed ID: 7040100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effectiveness of pyrazinamide combined with rifampicin and ethambutol in animal experiments].
    Tynystanova RI; Kozlova NV
    Probl Tuberk; 1984 Jul; (7):59-63. PubMed ID: 6483843
    [No Abstract]   [Full Text] [Related]  

  • 40. Re-treatment of pulmonary tuberculosis with rifampin and ethambutol.
    Lees AW; Allan GW; Smith J; Tyrrell WF; Fallon RJ
    Am Rev Respir Dis; 1972 Jan; 105(1):129-31. PubMed ID: 5007610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.